POU2F1

Across TCGA pan-cancer cohorts, POU2F1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated POU2F1 data layer compared with 26 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher POU2F1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated POU2F1 expression acts as an unfavorable survival marker, although some lineages such as UCEC and SKCM show a favorable association.

OV, UCEC, and SKCM are the cancer types where POU2F1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Median	III,IV	0.140	0.532	.002	6	view →
UCEC	DFS	Median	All	0.969	0.829	.026	6	view →
SKCM	OS	Median	All	1.000	0.776	.029	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

POU2F1–OV (DFS)

Open the OV breakdown →